{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:05:37Z","timestamp":1789805137521,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"DOI":"10.1007\/s00795-026-00476-0","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:16:10Z","timestamp":1789802170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological significance and prognostic value of the MSI1\/MTFR2 axis in clear cell renal cell carcinoma: linking stemness and mitochondrial dynamics"],"prefix":"10.1007","author":[{"given":"Dalia M.","family":"Thabet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman M.","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina M.","family":"Thabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"3","key":"476_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/wjon1279","volume":"11","author":"SA Padala","year":"2020","unstructured":"Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A (2020) Epidemiology of renal cell carcinoma. World J Oncol 11(3):79\u201387","journal-title":"World J Oncol"},{"issue":"3","key":"476_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F (2015) International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 67(3):519\u2013530","journal-title":"Eur Urol"},{"issue":"1","key":"476_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-018-3320-1","volume":"448","author":"AM Abdu Allah","year":"2018","unstructured":"Abdu Allah AM, El-Hefnway SM, Alhanafy AM, Zahran AM, Kasem HE (2018) Leptin receptor gene (A\/G) polymorphism rs1137101 and renal cell carcinoma. Mol Cell Biochem 448(1):137\u2013144","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"476_CR4","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V (2017) Renal cell carcinoma. Nat Rev Dis Primers 3(1):17009","journal-title":"Nat Rev Dis Primers"},{"key":"476_CR5","first-page":"99","volume":"15","author":"S Dhanji","year":"2023","unstructured":"Dhanji S, Wang L, Liu F, Meagher MF, Saidian A, Derweesh IH (2023) Recent advances in the management of localized and locally advanced renal cell carcinoma: a narrative review. Res Rep Urol 15:99\u2013108","journal-title":"Res Rep Urol"},{"issue":"6","key":"476_CR6","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1002\/jcp.27740","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K (2019) Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol 234(6):8381\u20138395","journal-title":"J Cell Physiol"},{"issue":"2","key":"476_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/1354750X.2022.2157875","volume":"28","author":"S Hoque","year":"2023","unstructured":"Hoque S, Dhar R, Kar R, Mukherjee S, Mukherjee D, Mukerjee N, Nag S, Tomar N, Mallik S (2023) Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance. Biomarkers 28(2):139\u2013151","journal-title":"Biomarkers"},{"issue":"1","key":"476_CR8","first-page":"313","volume":"12","author":"R Xiao","year":"2019","unstructured":"Xiao R, Yu Y, Shen S, Liu F, Kuang R (2019) Musashi1 promotes tumor metastasis and is a prognostic marker for renal carcinoma. Int J Clin Exp Pathol 12(1):313\u2013320","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"476_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13287-022-02891-3","volume":"13","author":"I Falke","year":"2022","unstructured":"Falke I, Troschel FM, Palenta H, Loeblein MT, Brueggemann K, Borrmann K, Eich HT, Goette M, Greve B (2022) Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation. Stem Cell Res Ther 13(1):212","journal-title":"Stem Cell Res Ther"},{"issue":"39","key":"476_CR10","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.3748\/wjg.v19.i39.6637","volume":"19","author":"RG Kuang","year":"2013","unstructured":"Kuang RG, Kuang Y, Luo QF, Zhou CJ, Ji R, Wang JW (2013) Expression and significance of Musashi-1 in gastric cancer and precancerous lesions. World J Gastroenterol 19(39):6637\u20136644","journal-title":"World J Gastroenterol"},{"key":"476_CR11","doi-asserted-by":"publisher","first-page":"1114231","DOI":"10.3389\/fphys.2023.1114231","volume":"14","author":"A Casanova","year":"2023","unstructured":"Casanova A, Wevers A, Navarro-Ledesma S, Pruimboom L (2023) Mitochondria: it is all about energy. Front Physiol 14:1114231","journal-title":"Front Physiol"},{"issue":"1","key":"476_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41420-025-02670-y","volume":"11","author":"X Qiu","year":"2025","unstructured":"Qiu X, Wang A, Wang J, Zhang Z, Tao L (2025) Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions. Cell Death Discov 11(1):375","journal-title":"Cell Death Discov"},{"key":"476_CR13","doi-asserted-by":"publisher","first-page":"11095","DOI":"10.2147\/CMAR.S272088","volume":"12","author":"W Lu","year":"2020","unstructured":"Lu W, Zang R, Du Y, Li X, Li H, Liu C, Song Y, Li Y, Wang Y (2020) Overexpression of MTFR2 predicts poor prognosis of breast cancer. Cancer Manag Res 12:11095\u201311102","journal-title":"Cancer Manag Res"},{"issue":"22","key":"476_CR14","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.18632\/aging.102442","volume":"11","author":"G Lu","year":"2019","unstructured":"Lu G, Li Y, Wang T, Lin W, Lu J, Ma Y, Chen Y, Ma H, Liu R, Li J (2019) Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells. Aging (Albany NY) 11(22):10203\u201310219","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"476_CR15","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.7150\/jca.58158","volume":"12","author":"H Zhu","year":"2021","unstructured":"Zhu H, Wang G, Zhu H, Xu A (2021) MTFR2, a potential biomarker for prognosis and immune infiltrates, promotes progression of gastric cancer based on bioinformatics analysis and experiments. J Cancer 12(12):3611\u20133622","journal-title":"J Cancer"},{"issue":"4","key":"476_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/bjc.2015.241","volume":"113","author":"Y Chang","year":"2015","unstructured":"Chang Y, An H, Xu L, Zhu Y, Yang Y, Lin Z, Xu J (2015) Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer 113(4):626\u2013633","journal-title":"Br J Cancer"},{"key":"476_CR17","doi-asserted-by":"crossref","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2016) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin 67(2):93\u201399","DOI":"10.3322\/caac.21388"},{"issue":"10","key":"476_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/PAS.0b013e318299f14a","volume":"37","author":"B Delahunt","year":"2013","unstructured":"Delahunt B, Egevad L, Montironi R, Srigley JR (2013) International society of urological pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol 37(10):1463\u20131468","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"476_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, Van De Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M (2017) Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno-oncology biomarkers working group: part 2. Adv Anat Pathol 24(6):311\u2013335","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"476_CR20","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","volume":"168","author":"I Frank","year":"2002","unstructured":"Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168(6):2395\u20132400","journal-title":"J Urol"},{"issue":"17","key":"476_CR21","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1200\/JCO.2001.19.17.3792","volume":"19","author":"A Zisman","year":"2001","unstructured":"Zisman A, Pantuck AJ, Figlin RA, Belldegrun AS (2001) Validation of the UCLA integrated staging system for patients with renal cell carcinoma. J Clin Oncol 19(17):3792\u20133793","journal-title":"J Clin Oncol"},{"issue":"5","key":"476_CR22","first-page":"4564","volume":"8","author":"L Ma","year":"2015","unstructured":"Ma L, Xu YL, Ding WJ, Shao HF, Teng YC (2015) Prognostic value of Musashi-1 in endometrioid adenocarcinoma. Int J Clin Exp Pathol 8(5):4564\u20134570","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"476_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.15430\/JCP.2021.26.4.250","volume":"26","author":"H Li","year":"2021","unstructured":"Li H, Zhu X, Zhang W, Lu W, Liu C, Ma J, Zang R, Song Y (2021) Association of high expression of mitochondrial fission regulator 2 with poor survival of patients with esophageal squamous cell carcinoma. J Cancer Prev 26(4):250\u2013256","journal-title":"J Cancer Prev"},{"issue":"4","key":"476_CR24","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1213\/ANE.0000000000005358","volume":"132","author":"P Schober","year":"2021","unstructured":"Schober P, Vetter TR (2021) Kaplan-Meier curves, log-rank tests, and Cox regression for time-to-event data. Anesth Analg 132(4):969\u2013970","journal-title":"Anesth Analg"},{"issue":"4","key":"476_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","volume":"31","author":"S Greenland","year":"2016","unstructured":"Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG (2016) Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol 31(4):337\u2013350","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"476_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s43046-020-00031-7","volume":"32","author":"M Elayadi","year":"2020","unstructured":"Elayadi M, Magdy S, Khalil E, Zekri W (2020) Management and outcome of pediatric metastatic Wilms\u2019 tumor at the national cancer institute. Egypt J Egypt Natl Canc Inst 32(1):19","journal-title":"Egypt J Egypt Natl Canc Inst"},{"issue":"2","key":"476_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/genes14020355","volume":"14","author":"NM Abd El-Fadeal","year":"2023","unstructured":"Abd El-Fadeal NM, Ellawindy A, Jeraiby MA, Qusti SY, Alshammari EM, Alzahrani AK, Ismail EA, Ehab Z, Toraih EA, Fawzy MS, Mohamed MH (2023) HSP70 expression signature in renal cell carcinoma: a clinical and bioinformatic analysis approach. Genes (Basel) 14(2):355","journal-title":"Genes (Basel)"},{"issue":"4","key":"476_CR28","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s12253-015-9943-6","volume":"21","author":"PX Chen","year":"2015","unstructured":"Chen PX, Li QY, Yang Z (2015) Musashi-1 expression is a prognostic factor in ovarian adenocarcinoma and correlates with ALDH-1 expression. Pathol Oncol Res 21(4):1133\u20131140","journal-title":"Pathol Oncol Res"},{"issue":"5","key":"476_CR29","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.3892\/ol.2017.5879","volume":"13","author":"Z Shou","year":"2017","unstructured":"Shou Z, Jin X, He X, Zhao Z, Chen Y, Ye M, Yao J (2017) Overexpression of Musashi-1 protein is associated with progression and poor prognosis of gastric cancer. Oncol Lett 13(5):3556\u20133566","journal-title":"Oncol Lett"},{"issue":"8","key":"476_CR30","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v17.i8.107013","volume":"17","author":"YX Niu","year":"2025","unstructured":"Niu YX, Hu M, Zhao WF, Yang HJ (2025) Expression of stem cell marker Musashi-1 and its relationship with survival prognosis in patients with resectable esophageal squamous cell carcinoma. World J Stem Cells 17(8):107013","journal-title":"World J Stem Cells"},{"issue":"5","key":"476_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.neo.2019.02.006","volume":"21","author":"JC Lin","year":"2019","unstructured":"Lin JC, Tsai JT, Chao TY, Ma HI, Liu WH (2019) Musashi-1 enhances glioblastoma migration by promoting ICAM1 translation. Neoplasia 21(5):459\u2013468","journal-title":"Neoplasia"},{"issue":"27","key":"476_CR32","doi-asserted-by":"publisher","first-page":"42485","DOI":"10.18632\/oncotarget.9890","volume":"7","author":"HY Chen","year":"2016","unstructured":"Chen HY, Lin LT, Wang ML, Lee SH, Tsai ML, Tsai CC, Liu WH, Chen TC, Yang YP, Lee YY, Chang YL (2016) Musashi-1 regulates AKT-derived IL-6 autocrinal\/paracrinal malignancy and chemoresistance in glioblastoma. Oncotarget 7(27):42485\u201342501","journal-title":"Oncotarget"},{"issue":"8","key":"476_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082212","volume":"15","author":"L Kruk","year":"2023","unstructured":"Kruk L, Mamtimin M, Braun A, Anders HJ, Andrassy J, Gudermann T, Mammadova-Bach E (2023) Inflammatory networks in renal cell carcinoma. Cancers (Basel) 15(8):2212","journal-title":"Cancers (Basel)"},{"key":"476_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.832517","volume":"12","author":"Z Lian","year":"2022","unstructured":"Lian Z, Pang P, Zhu Y, Du W, Zhou J (2022) Prognostic value and potential mechanism of MTFR2 in lung adenocarcinoma. Front Oncol 12:832517","journal-title":"Front Oncol"},{"key":"476_CR35","doi-asserted-by":"publisher","first-page":"1505071","DOI":"10.3389\/fmed.2024.1505071","volume":"11","author":"Z Niu","year":"2025","unstructured":"Niu Z, Zhang Y, Wang Y, Liu D, Wang J, Shi T, Xu X, Li L (2025) MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p\/PI3K\/Akt signaling pathway. Front Med (Lausanne) 11:1505071","journal-title":"Front Med (Lausanne)"},{"key":"476_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105095","author":"Q Huang","year":"2023","unstructured":"Huang Q, Han Y, Shen E, Feng Z, Peng Y, Gao L, Gao Y, Liu Y, Li W, Liu P, Chen Y (2023) MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma. iScience. https:\/\/doi.org\/10.1016\/j.isci.2022.105095","journal-title":"iScience"},{"issue":"3","key":"476_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/med4.72","volume":"2","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Cao H, Yang F, Wang X, Xu Z, Cheng M, Yang S, Tian X, Zhang N, Xie Y (2024) Comprehensive analyses of nuclear mitochondria-related genes in the molecular features, immune infiltration, and drug sensitivity of clear cell renal cell carcinoma. Medicine Advances 2(3):238\u2013253","journal-title":"Medicine Advances"},{"issue":"1","key":"476_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04027-4","volume":"21","author":"WJ Zhong","year":"2023","unstructured":"Zhong WJ, Zhang J, Duan JX, Zhang CY, Ma SC, Li YS, Yang NS, Yang HH, Xiong JB, Guan CX, Jiang ZX (2023) TREM-1 triggers necroptosis of macrophages through mTOR-dependent mitochondrial fission during acute lung injury. J Transl Med 21(1):179","journal-title":"J Transl Med"},{"issue":"5","key":"476_CR39","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.hoc.2023.04.011","volume":"37","author":"NH Shirole","year":"2023","unstructured":"Shirole NH, Kaelin WG Jr (2023) VHL and HIF at the center of RCC biology. Hematol Oncol Clin North Am 37(5):809\u2013825","journal-title":"Hematol Oncol Clin North Am"},{"issue":"16","key":"476_CR40","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.1093\/nar\/gkw372","volume":"44","author":"AP Bertolin","year":"2016","unstructured":"Bertolin AP, Katz MJ, Yano M, Pozzi B, Acevedo JM, Blanco-Obregon D, G\u00e1ndara L, Sorianello E, Kanda H, Okano H, Srebrow A (2016) Musashi mediates translational repression of the Drosophila hypoxia inducible factor. Nucleic Acids Res 44(16):7555\u20137567","journal-title":"Nucleic Acids Res"},{"key":"476_CR41","first-page":"54","volume":"8","author":"Z Dong","year":"2025","unstructured":"Dong Z, Li S, Li M, Fan M, Chen K, Li A, Wang K, Zhang X (2025) Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall? Cancer Drug Resist 8:54","journal-title":"Cancer Drug Resist"},{"issue":"2","key":"476_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.21037\/tau.2020.01.21","volume":"9","author":"Y Lu","year":"2020","unstructured":"Lu Y, Song Y, Xu Y, Ou N, Liang Z, Hu R, Zhang W, Kang J, Wang X, Liu L, Yang Y (2020) The prevalence and prognostic and clinicopathological value of PD-L1 and PD-L2 in renal cell carcinoma patients: a systematic review and meta-analysis involving 3,389 patients. Transl Androl Urol 9(2):367\u2013380","journal-title":"Transl Androl Urol"},{"key":"476_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gene.2018.09.005","volume":"679","author":"Y Song","year":"2018","unstructured":"Song Y, Hu J, Chen Q, Guo J, Zou Y, Zhang W, Chen X, Hu W, Huang P (2018) Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects. Gene 679:241\u2013252","journal-title":"Gene"},{"issue":"23","key":"476_CR44","doi-asserted-by":"publisher","first-page":"2416419","DOI":"10.1002\/advs.202416419","volume":"12","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhou B, Yang J, Ren C, Luo J, Li Z, Liu Q, Huang Z, Wu Z, Jiang N (2025) MTFR2-mediated fission drives fatty acid and mitochondrial co-transfer from hepatic stellate cells to tumor cells fueling oncogenesis. Adv Sci (Weinh) 12(23):2416419","journal-title":"Adv Sci (Weinh)"},{"issue":"19","key":"476_CR45","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.1002\/cam4.4206","volume":"10","author":"T Peng","year":"2021","unstructured":"Peng T, Dong SQ, Song YX, Hou D, Wang L, Li B (2021) Key sunitinib-related biomarkers for renal cell carcinoma. Cancer Med 10(19):6917\u20136930","journal-title":"Cancer Med"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-026-00476-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-026-00476-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-026-00476-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:16:12Z","timestamp":1789802172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-026-00476-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":45,"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1007\/s00795-026-00476-0","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"28 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None to declare.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Research Ethics Committee (IRB Approval Protocol No. 1915, granted in February 2026.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}